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The DNA mutation produced by cellular repair of a CRISPR/Cas9-generated double-
strand break determines its phenotypic effect. It is known that the mutational outcomes 
are not random, and depend on DNA sequence at the targeted location. Here we 
systematically study the influence of flanking DNA sequence on repair outcome by 
measuring the edits generated by >40,000 guide RNAs in synthetic constructs. We 
performed the experiments in a range of genetic backgrounds and using alternative 
CRISPR/Cas9 reagents. In total, we gathered data for >109 mutational outcomes. The 
majority of reproducible mutations are insertions of a single base, short deletions, or 
longer microhomology-mediated deletions. Each gRNA has an individual cell-line 
dependent bias toward particular outcomes. We uncover sequence determinants of the 
produced mutations, and use these to derive a predictor of Cas9 editing outcomes. 
Improved understanding of sequence repair will allow better design of gene editing 
experiments. 
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Introduction 
CRISPR/Cas9 is a transformative DNA editing technology1. It operates by recruiting the Cas9 
nuclease to a genomic locus with a protospacer-adjacent motif (PAM) using a short synthetic 
guide RNA (gRNA) with a 18-20 nt sequence matching the desired target. Cas9 then cuts DNA 
at that location, and when the double strand break is repaired by cellular machinery, frameshift 
mutations can occur, disabling translation of the correct protein.  
 
Cas9-generated mutations result from imperfect action of DNA repair pathways that are 
activated to remedy the double strand break. The major repair mechanisms include non-
homologous end joining, which re-ligates the generated ends, often introducing errors of a few 
nucleotides; and microhomology-mediated end joining, in which short tracts of local matching 
sequence anneal, ultimately resulting in deletion of the intervening bases2,3. Choice of pathway 
is influenced by a host of factors including cell cycle stage, and availability of repair enzymes4,5. 
It has been shown, that the frequency of alternative Cas9 editing outcomes (“the mutational 
profile”; Figure 1) is largely reproducible, and depends on the targeted sequence6-10, indicating 
that the errors in repair occur in a non-random manner. Although DNA repair pathways and their 
key components have been characterized, the biases that favor one mutation over another are 
not fully understood, especially for the breaks inflicted by Cas9. 
 
To date, mutational profiles have not been measured at scale. The main barrier has been the 
labor necessary to individually amplify the sequence at each of the targeted loci. The largest 
current dataset of genomic repair profiles comprises 436 profiles examining 96 unique gRNA 
sequences using the Cas9 protein from S. pyogenes7, recently followed up with studies of 
additional target sites11,12. More gRNAs (~1,400) were employed in a study that introduced the 
target and gRNA into cells simultaneously13, but the low probability of a gRNA and its 
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corresponding target meeting in the same cell resulted in an average mutation rate of 0.2%, and 
insufficient data for a comprehensive analysis. An approach introducing gRNA and target in the 
same synthetic construct has been used for the Cpf1 nuclease14, and the Staphylococcus 
aureus Cas9 enzyme15. Both profiled proteins have a shorter RNA scaffold sequence, enabling 
a simpler library cloning procedure to assess more gRNAs. However, differences between both 
the proteins themselves and the characteristics of the DNA breaks they generate mean that 
these results are not directly applicable to Cas9. Whereas the Cpf1 data was used to develop 
an algorithm that predicts indel frequencies, no attempt was made to predict the SaCas9-
generated mutation frequencies or the exact repair outcomes for either of the enzymes. 
 
Here, we present a large-scale measurement of Cas9-generated gRNA repair profiles. We 
synthesized over 40,000 DNA constructs, each containing both a gRNA and its target, 
introduced them into Cas9-expressing cell lines, and sequenced the targeted loci. We confirm 
that our measurements are informative of events at endogenous sites, describe the dominant 
outcomes and their sequence dependence in a range of cell lines, and present an accurate 
predictive model for forecasting the outcomes of an edit. 
Results 
Measuring repair outcomes en masse 
The main hurdle in measuring a large number of repair outcomes is the need to selectively 
amplify each targeted locus. To circumvent this, we designed a construct that encodes a gRNA 
expression cassette together with its 23nt PAM-endowed target sequence within a larger 79nt 
variable context, and flanked by common PCR priming sites on both sides (Figure 1, S1). The 
variable context allowed us to systematically change the local sequence to directly test its 
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influence on the repair outcome, and to unambiguously assign each sequenced target to its 
gRNA-target pair of origin. Using high throughput oligonucleotide synthesis followed by custom 
cloning reactions (Online Methods), we generated several libraries of gRNA-target pairs, with a 
total of 41,630 constructs. We delivered these into cells using lentiviral infection at 0.5-0.6 
multiplicity (Table S1), cultured for seven days to ensure saturated editing while avoiding drift 
(Figure S2-S4), then isolated genomic DNA, amplified the target sequence in its context, and 
sequenced at high coverage (Figure S5) to measure the frequency of insertions and deletions 
that had occurred. 
Synthetic repair profiles are reproducible, and faithfully capture endogenous repair 
outcomes 
First, we demonstrate that our measurements are sequence-specific and reproducible in the 
human chronic myelogenous leukemia (K562) cell line. Here and elsewhere, we use the 
symmetric Kullback-Leibler (“KL”) divergence, a natural information-theoretic metric related to 
relative entropy of probability distributions, to quantify similarity of outcome frequencies (Online 
Methods). Given adequate read coverage, profiles from biological replicates measuring the 
same gRNA target were similar, whereas targets of randomly selected gRNAs had markedly 
different repair outcomes (median KL=0.70 vs 4.8; Figure 2A-C; 6,218 gRNAs from 
conventional set, Online Methods). The fraction of frameshift edits, a factor that is arguably most 
important for knock-out experiments, is also highly correlated between biological replicates 
(Pearson’s R=0.9; Figure 2D). Together, these results show that the mutational profiles are 
reproducible and sequence-specific. Given the negligible influence of whether the 
conventional16 or improved17 gRNA scaffolds were used (median KL=0.77; Figure 2A, 2C), the 
improved version is employed in all following experiments, unless noted otherwise.  
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We next tested whether the measurements from our synthetic targets are a good proxy for 
repair outcomes at endogenous loci. To do this, we took advantage of data from the largest 
scale study of editing outcomes to date7, in which 223 human genomic targets for 96 unique 
gRNAs were individually amplified and sequenced (“endogenous outcomes”). Those 77 of these 
gRNAs that we were able to successfully clone were included in our library with their genomic 
contexts (Online Methods). Concordance between synthetic and endogenous outcomes was 
very good for individual cases (Figure 2A), on the whole (median  KL=1.1; Figure 2B), and for 
recapitulating frameshift edit fraction (Pearson’s R=0.78, Figure 2D). Nevertheless, the 
observed differences were larger than for biological replicates of our assay, so we inspected the 
reasons for this. We identified two causes. First, sampling noise due to low sequencing 
coverage leads to increased divergence (Figure 2E). Second, deletions and rearrangements 
larger than our measurement size limit of 30nt (Online Methods), and which can be prevalent18, 
explain three of the four cases with sufficient read counts that markedly differ (KL > 3). The 
remaining case (“Overbeek 25”) diverges despite high reproducibility between synthetic 
measurements (Figure S6). Given that our construct only contains 79nt of local context due to 
limitations of oligonucleotide synthesis, yet produces very similar outcomes for 94% of 
measured cases with sufficient reads (67/71), this result confirms that sequence surrounding the 
cut site is the major determinant of Cas9-induced mutational outcomes. We also tested for the 
influence of chromatin state on the profile similarity, but found that the average divergence 
between endogenous and synthetic measurements did not differ for endogenous targets in 
active or repressed chromatin (Table S2).  
Repair outcomes in K562 cells are diverse 
After concluding that our assay faithfully and reproducibly captures a majority of endogenous 
mutational outcomes, we surveyed a collection of 6,568 gRNAs that target human genes 
(“Genomic gRNA-Targets”, Online Methods) that we expect to be representative of gRNAs in 
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practical use, in triplicate. We observed that single nucleotide insertions and deletions were 
most common, with larger insertions occurring only rarely, and shorter deletions favoured over 
longer ones (Figure 3A). However, a long tail of larger deletion events was present. 
 
Despite shorter deletions being more frequent, most of the Cas9-generated mutations (58%) 
resulted in a deletion of at least three base pairs (Figure 3B). About half of these (31% of total) 
occurred between repeating sequences at least 2nt (“microhomology”). Deletions of one or two 
base pairs made up 18% of all observations, and while insertions of a single base were the 
most common type of outcome overall (13%), larger insertions were rare (3% of all mutations). 
More complex outcomes with both insertion and deletion events were present in 8% of 
measured reads. 
 
Given a similar basal activity of the different DNA repair pathways in all cells of the assay, it is 
natural to hypothesize that repair outcomes of individual gRNA targets largely conform to the 
average trend observed above. In fact, there is substantial variability in the relative frequency of 
different outcome types (Figure 3C). Insertions, single and double nucleotide deletions, and 
microhomology-mediated deletions can all be present at frequencies ranging from near 0 to 
over 50% depending on the target, further highlighting the sequence-specific nature of the repair 
process.  
 
Repair outcomes are biased towards particular alleles. The same specific mutation was most 
frequent in all three biological replicates for over 60% of gRNAs (Figure 3D), but mutations from 
different classes were not favored equally. When the consensus existed, it was almost always a 
single nucleotide insertion (36%), microhomology-mediated deletion of at least 3nt (34%), or a 
deletion of one or two bases (30%), and could make up over half of all mutations for that gRNA 
with reproducible frequency (Pearson’s R > 0.83; Figure 3C, S7). In contrast, whereas deletions 
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of at least 3nt without microhomology, larger insertions (I>1), and more complex mutations (I+D) 
are collectively common (38%, Figure 3B), their frequency for each gRNA is lower and less 
reproducible (Pearson’s R < 0.27; Figure 3C, S7), so that they form less than 1% of the 
reproducibly most frequent outcomes (Figure 3D). 
 
Overall, half of the measured gRNAs have a single outcome that contributed at least 20% of the 
observations, and 11% have an outcome that contributed at least 40% (Figure 3E). Yet although 
on average, the six most frequent alleles per construct account for the majority of its observed 
mutations, 25 alleles collectively explain only 72% of the data (Figure 3F), indicating a large 
number of low frequency events. Some of these may be artifactual, but we expect them to form 
a minority, as we observed an order of magnitude fewer unique mutations in a control 
experiment lacking Cas9 (Figure S8). Additionally, frequencies of alleles assayed at different 
time points (seven and 10 days post infection) from the same replicate are more concordant 
than those of biological replicates (Figure S7), indicating re-sampling of existing low frequency 
alleles, rather than stochastic measurement noise. Together with evidence of profile 
reproducibility above, this paints a picture of a complex, yet not completely random repair 
process for Cas9-generated breaks. 
Repair outcomes depend on local sequence properties 
Given the reproducible and sequence specific nature of repair outcomes, we next investigated 
their sequence determinants. For all analyses in this section, we used a larger explorative set of 
27,906 constructs that lack a counterpart in the human genome, and cover a broad range of 
sequence characteristics (Online Methods). Unless noted otherwise in text or figures, all 
constructs are included in the analysis. 
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Given that microhomology is known to bias repair of Cas9-induced double strand breaks6,19, we 
first systematically evaluated repair outcomes of targets with different microhomology spans (3-
15nt), and separating distances (0-20nt). We observed that the fraction of mutations that could 
be attributed to microhomology-mediated end joining was higher when the matching sequences 
were separated by shorter distances (Figure 4A). This trend held for all spans of 
microhomology, but was more pronounced for longer tracts (e.g. Pearson’s R=-0.7 for 10 
matching bases vs. R=-0.2 for three matching bases; Figure 4B).  
 
We next assessed whether imperfectly matching microhomologous sequences also generate 
corresponding deletions using the gRNAs designed with zero, one or two mismatches in the 
microhomology region (“Microhomology Mismatch gRNA-Targets”; 571 constructs with 
mismatches). Indeed, the same alleles are generated at a 30% reduced rate if one mismatch is 
present, and 50% reduced rate if two (Figure 4C). The presence of mutations in one or the other 
side of the cut allowed us to further test whether sequence from one side is preferentially 
retained, but we found no bias either for microhomology-mediated deletions (Figure S9) or the 
rest (Figure S10). We also observed that sequences with low GC fraction were not as frequently 
used as repair template as those with higher GC (Figure S11), suggesting preference for a 
higher melting temperature in the resulting duplex. 
 
There is evidence that single base insertions favor a repeat of the PAM-distal nucleotide 
adjacent to the cut site in yeast, and to an unknown extent, in humans9. In the following, we 
consider the alleles that are most frequent for a gRNA in all three replicates (“dominant 
mutations”, Figure 3D). Contrary to the lack of directional bias in deletions (Figure S9, S10), we 
observed that for over 99% of the 6,572 dominant single base insertions, the PAM-distal 
nucleotide was repeated (Figure 4D). Further, for 49% of all gRNAs with a thymine as the PAM-
distal base at the cut site, insertion of another thymine is the most frequent outcome, whereas 
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this is the case for only 1.6%, 15% and 28% of gRNAs with a guanine, cytosine and adenosine, 
respectively (Figure 4E).  
 
A similar strong bias is present for small deletions. We observed that 77% of dominant single 
base deletions correspond to removal of a repeating nucleotide at the cut site (Figure 4F). 
Deleting one cytosine from a pair was most common (36%), dominating for 30% of 1,843 
gRNAs with a cytosine on both sides of the cut. When repeat of another nucleotide was present, 
its contraction dominated for 12-16% of gRNAs, whereas only 1.6% of gRNAs without a repeat 
produced a dominant single base deletion (Figure 4G).  
 
Repeat removal was also favored for two-base deletions. Half of dominant dinucleotide 
deletions contract a repeat of two bases at the cut site, and a further 17% remove a single 
repeated nucleotide separated by another nucleotide (Figure 4H). In the remaining cases (31%), 
both bases are removed from one or other side of the cut, but a single base is never removed 
from both sides. Notably, if a dinucleotide repeat is present at the cut site of a gRNA, its 
contraction is very likely to be the dominant repair outcome for that gRNA (up to 77% of gRNAs 
with an AGAG motif; Figure 4I), and preference for the PAM-distal pattern is the opposite of a 
single base deletion, with thymines giving rise to lower rates (10%, 36/344), while guanines are 
preferred (62%, 233/377). If alternative sequence configurations are present at the cut site, 
sequence biases are present (Figure S12), but deleting two bases never dominates for more 
than 5% of the gRNAs in these other cases (Figure S13). 
Mutational outcomes vary with cell line and some Cas9 modifications 
Cells can differ in activity of repair processes and/or DNA sequence, both of which influence 
double strand break repair outcomes20. We next performed our assay in human induced 
pluripotent stem cells (iPSCs), mouse embryonic stem cells (mESCs), Chinese hamster ovary 
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(CHO) epithelial cells, as well as human retina epithelial immortalized cells (RPE-1) and 
leukemic near-haploid (HAP1) cell lines. We used the same genomic gRNAs as for initial 
characterization (“Genomic gRNA-Targets” set, Online Methods, e.g. Figure 3), but restricted to 
the 3,777 with at least 20 mutated reads in all cell lines (median read numbers in Figure 5A). 
 
The overall distribution of repair outcome types was not the same across the different cell lines 
and organisms studied (Figure 5A), but repair profiles of individual gRNAs remained similar to 
each other (median KL < 2; Figure 5B, example in Figure S14). Some relative changes of 
preferred mutation classes were notable. Large insertions occurred more frequently in stem 
cells, with a 2.6x and 1.7x increase in human iPSCs and mESCs, respectively, over K562 
levels. However, the frequency of these mutations remained low, and not reproducible (Figure 
S15), which also explains the increase in overall between-replicate divergence (Figure 5B). 
Deletions attributed to microhomology-mediated end joining were 40% less frequent in RPE-1 
samples compared to K562; instead these cells displayed more than double the rate of single 
base insertion (37% in RPE-1 vs 14% in K562). The same bias was present in CHO cells, 
whereas both iPSC and mouse stem cells favored microhomology-mediated deletions at the 
expense of single base insertions (Figure 5A). This trend was recapitulated in the mutation class 
of the dominant mutation for each gRNA, which changed depending on the cell line (Figure 5D). 
We found little influence of the genetic background on the link between microhomology and 
repair outcomes (Figure 5C), replicating our findings in K562 in other lines and species.  
 
Multiple Cas9 effector proteins with augmented properties have been engineered, which could 
also give rise to changes in observed mutations. We thus considered alternative CRISPR/Cas9 
reagents in K562 cells, both enhanced Cas9 eSpCas9(1.1) (eCas9)21) and Cas9 fused to Three 
Prime Repair Exonuclease 2 (TREX2), which is known to increase deletion size13,22. eCas9 
behaved similarly to Cas9 (Figure 5A and B), albeit with a slower editing saturation (Figure S2), 
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whereas outcomes in the Cas9-TREX2 fusion protein line were markedly different from the 
others (Figure 5B). Cas9-TREX2 mutations were shifted towards larger deletions (Figure 5D 
and E), and favoured ligation of the intact PAM-proximal side with a deletion on the PAM-distal 
side (Figure S16), at the expense of frequent microhomology-mediated deletions (Figure 5C, 
S17). The generation of less biased and larger deletions, as generated by this fusion, could be 
beneficial in some contexts. We also tested a Cas9-2A-TREX2 construct harboring a 2A linker 
peptide which results in equal expression of monomeric Cas9 and TREX2. This construct did 
not generate additional larger deletions as observed for Cas9-TREX2 fusion, but did increase 
the frequency of single base deletions while reducing microhomology-mediated ones (Figure 
S17, S18). Combined, these data are consistent with the function of TREX2 as an 
exonuclease23 that promotes repair via the canonical non-homologous end joining pathway, 
resulting in small deletions that are not mediated by microhomology24,25.  
Repair outcomes can be accurately predicted 
So far, we have demonstrated that the repair outcomes are reproducible, biased, dependent on 
the local sequence, and mostly consistent across genetic backgrounds. These observations 
suggest that mutations generated by Cas9 ought to be predictable from sequence alone. To test 
this hypothesis, we developed a computational predictor of the mutational outcomes of a given 
gRNA, which we call FORECasT (Favoured Outcomes of Repair Events at Cas9 Targets). To 
accomplish this, we first generated candidate mutations for each gRNA, and derived features for 
them based on local sequence characteristics (Online Methods). We then split the set of 
available gRNAs into training, validation, and test sets, and trained a multi-class logistic 
regression model that minimizes the average KL divergence between predicted and actual 
repair profiles (Figure 6A).  
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The theoretical prediction accuracy limit is measurement repeatability. FORECasT achieves 
performance close to this limit, with the average KL between predicted and measured profiles 
only a little higher than between measurements in biological replicates (0.68 vs 0.65; Figure 6B; 
examples of predictions at the quartiles and whiskers in Figure S19). Frequencies of individual 
mutations that were reproducible (I1, D1, D2 and D>2 with microhomology) were also 
correspondingly well predicted (Figure S20). As a consequence, we could accurately predict the 
percentage of mutations that do not disrupt the reading frame on held-out validation data 
(Pearson’s R=0.81 for prediction vs 0.89 for replicates; Figure 6C, 2D). Despite being trained on 
K562 cells, FORECasT also achieves good accuracy on other cell lines (median KL range from 
0.79 in CHO cells to 1.25 in mouse ES cells; Figure S21), with the magnitude of discrepancies 
consistent with shifts in the repair profiles (Figure 5A, 5B).  
 
The sequence features with the largest weights mirror those that we observed to induce a bias 
in the outcomes, for example linking high frequency single nucleotide insertions to a repeat of a 
PAM-distal T nucleotide (Table S3). Individual deletion-related features (over 2000 total) had 
lower weights, most likely due to their larger quantity. Substantial biases in feature weights 
highlight the expected microhomology-related properties explored above, amongst others, and 
further experiments may yet elucidate additional sequence characteristics that promote 
particular repair outcomes.  
 
Finally, we tested the extent to which the predicted rates of in frame mutation explain the 
variability in gRNA efficacy seen in existing gene knock-out experiments and large scale 
screens. We predicted mutational outcomes for gRNAs targeting 10 genes26, but while the 
estimated fraction of frameshift edits is concordant with the measurements where available (12 
gRNAs; Figure 6C, S22, Table S4), it does not explain the observed phenotypic variation 
(Figure S23). We also calculated correlations between the predicted fraction of out-of-frame 
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mutations, and gRNA efficacy for essential gene gRNAs in three large scale screening datasets 
(Online Methods), and found a significant, albeit small, link (Figure S24). The strength of the 
association increased with library design iterations and quality, suggesting that ability to 
generate frameshift mutations is an increasingly important consideration once other sources of 
variability have been accounted for. In agreement with26, we further observed a weak but 
consistent association between the predicted fraction of out-of-frame mutations and phenotypic 
effect for gRNA that target outside protein domains (Figure S25), indicating that it is more 
important to disrupt the reading frame in those regions.  
 
These results demonstrate that repair outcomes can be predicted from sequence alone, and in 
a manner that is expected to generalise to all sites in the genome. We have made the predictor 
available as a webtool at https://partslab.sanger.ac.uk/FORECasT, and as a command line tool 
on GitHub at  https://github.com/felicityallen/SelfTarget.  
Discussion 
We have presented the—to our knowledge—most comprehensive study of DNA double strand 
break repair outcomes to date. The Cas9-generated alleles show strong sequence dependent 
biases that are reproducible and predictable for dominant categories of mutation (single base 
insertions, small deletions, and microhomology-mediated deletions), despite some variability 
between genetic backgrounds and species. 
 
Stem cells (human iPSCs and mouse ESCs) had a higher rate of large insertions than other 
lines, and favored microhomology-mediated deletions. These biases likely reflect different 
absolute and relative activities of the various DNA repair mechanisms. Preference for 
microhomology-mediated repair in stem cells may be linked to increased rates of homology-
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directed repair, which shares the initial resection step4, whereas favoring of single based 
insertions in CHO and RPE-1 lines indicate elevated canonical end-joining activity. The higher 
incidence of large insertions in stem cells could similarly be explained by aberrant homology-
directed repair, where strand invasion occurs in the wrong place, such that DNA synthesis 
before strand displacement leads to additional sequence. 
 
The strong sequence biases observed here for single nucleotide insertions, as previously also 
seen in yeast, and to some extent humans9 could be explained by a model where the Cas9 
protein stays bound to the PAM-proximal side of the cut while the staggered one-nucleotide 
overhang on the PAM-distal side10,17 is filled by DNA polymerase, and re-ligated via the non-
homologous end joining pathway9,28. Favoring of thymine insertion by this event could indicate 
either a preference of the DNA repair enzymes (especially polymerases), difference in 
availability of the required nucleotide triphosphate for incorporation, or propensity of Cas9 to 
make a staggered, rather than blunt cut when thymine is present. Finally, removal of one or two 
repeating nucleotides is the most frequent deletion, which could be achieved by processing and 
re-ligating the ends at the cut via a similar staggered intermediate. 
 
Our assay was limited to confident detection of deletions of at most 30 base pairs, as the longer 
deletions would also remove the unique sequence we use to assign the measurement to a 
gRNA-target pair. Recent reports indicate that substantially larger events happen at non-
negligible frequency18, and indeed, some such outcomes explain the large discrepancies 
observed for a small number of gRNAs between our measurements and endogenous profiles. 
Nevertheless, in 94% of cases measured, there is good agreement between the outcomes we 
measured in our synthetic targets, and those at genomic targets.  
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Many genetic diseases, like Huntington’s or Fragile X syndrome, are due to expansions of short 
tandem repeats29. Such repetitive sequence serves as excellent substrate for microhomology-
mediated repair, and potential correction using Cas9, especially if they also harbor a PAM site, 
like the CGG expansion of the FMR2 gene in fragile XE syndrome30. In the future, contraction of 
such rogue expansions could be explored as a therapy option, as the low efficacy allele 
replacement is not required, and simply generating a double strand break would shorten the 
pathogenic repeat. Indeed, a few preliminary efforts in this direction have already given 
promising results31-33, but given the possible unintentional genomic damage18, utmost rigor is 
required to demonstrate safety before any applications in humans. The data and model 
presented here will help in guiding gRNA design towards the desired outcomes for genome-
wide screens and bespoke edits. 
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Figure Legends 
Figure 1. Mutational profiles generated by CRISPR/Cas9, and a method for their high-
throughput measurement. High throughput measurement of repair outcomes. Constructs 
containing both a gRNA and its target sequence (matched colors) in variable context (grey 
boxes) are cloned en masse into target vectors containing a human U6 promoter (green) (1), 
packaged into lentiviral particles, and used to infect cells (2), where they generate mutations at 
the target (3). DNA from the cells is extracted, the target sequence in its context amplified with 
common primers, and the repair outcomes (location, size, and sequence of mutation) 
determined by deep short read sequencing (4). 
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Figure 2. Synthetic mutational profiles are reproducible, specific to individual gRNAs and 
closely resemble endogenously measured profiles in human K562 cells.  
A. Example of measured repair profile reproducibility for one gRNA-target pair. DNA sequence 
of the target (top) is edited to produce a range of synthetic outcomes that employ the improved 
gRNA scaffold (green bars) and conventional gRNA scaffold (blue bars), contrasted to 
endogenous measurements (orange bars). The proportions (x-axis) of the four most frequent 
mutational outcomes (e.g. “D3” - deletion of three base pairs depicted, “I1” - insertion of a single 
“A” at cut site, etc.; y-axis) is consistent between the experiments. Stretches of microhomology 
(green) and inserted sequences (red) are highlighted at the cut site (dashed vertical line).  
B. Synthetic measurements faithfully capture endogenous outcomes. Symmetrized Kullback-
Leibler divergence (white to black color scale) between synthetic repair profile measurements in 
K562 cells (x-axis) and endogenous repair profiles from van Overbeek et al. (y-axis; at least 100 
reads in our synthetic samples).  
C. Synthetic measurements are reproducible and gRNA-specific, irrespective of gRNA scaffold 
used. Box plots (orange median line, quartiles for box edges, 95% whiskers) of symmetrised KL 
divergences between two measurements of the same target (left), or between measurements of 
randomly selected target pairs from the same set (middle, right). Green boxes: comparison of 
biological replicates of the same library using the improved scaffold; blue boxes: comparison of 
matched measurements between libraries employing the conventional scaffold, and the 
improved scaffold; median mutated read numbers per gRNA in parentheses. The 6,218 gRNAs 
used are from the “Conventional Scaffold gRNA-Targets” set (Online Methods); improved 
scaffold is used throughout the rest of the paper.  
22 
D. Frame information is reproducible between replicates, and well correlated with endogenous 
outcomes. Blue markers: Percentage of in-frame outcomes in our synthetic measurements (y-
axis) contrasted against another biological replicate (x-axis; Pearson’s R=0.89, gRNAs as in C, 
improved scaffold only). Orange markers: same, but contrasting information from combined 
synthetic replicates (y-axis) against 68 endogenous measurements (x-axis; Pearson’s R=0.78, 
gRNAs as in B, excluding four with majority of large deletions not captured in our assay).  
E. Low coverage and large deletions are the main sources of discrepancy between endogenous 
and synthetic measurements. Symmetrized KL divergence (y-axis) between endogenous and 
synthetic measurements of editing outcomes (individual markers; gRNAs as in B) is dependent 
on the sequencing coverage (log10(number of obtained reads), x-axis), and frequency of very 
large deletions (colors). Three target sequences that frequently give rise to very large deletions 
(red, purple) are not well captured by our assay design. 
 
Figure 3. Mutational profiles are diverse and biased in K562 cells, as measured using 
6,568 gRNAs with a median 991 sequenced reads with mutations per target.  
A. Single base insertions are most common, with a long tail of moderately long deletions. The 
frequency (y-axis) of deletion or insertion size (x-axis), averaged across sequence targets 
present in the genome.  
B. Editing outcome types are diverse. The percent occurrence per gRNA (area of wedge) of 1nt 
insertions (I1, blue), larger insertions (I > 1, teal), single base deletions (D1, red), dinucleotide 
deletions (D2, orange), larger deletions likely mediated by microhomology (D > 2, MH; dark 
green), other larger deletions (D > 2, no MH; light green), and more complex alleles (I + D, 
grey), measured in K562 cells, and averaged across genomic sequence targets.  
23 
C. Per-gRNA event frequencies differ across indel classes. Number of individual indels (y-axis, 
log10-scale) as a percentage of all mutations observed for their gRNA (x-axis) separated by 
mutation class (rows). Colors as in (B).  
D. Specific single base insertions and microhomology-mediated deletions are the most frequent 
reproducible mutation classes. The percent of gRNAs (area of wedge) that have the same 
specific allele as their most frequent mutation in all three replicates, stratified by indel class 
(colors). ‘No consensus’: inconsistent most frequent mutation across replicates.  
E. A single allele can account for a large fraction of editing outcomes for a gRNA. Number of 
gRNAs (y-axis) with the frequency of its most common outcome (x-axis) in K562 cells.  
F. A small number of outcomes explains most of the observed data, but many low frequency 
alleles are present. Cumulative fraction of observed data (y-axis) matching an increasing 
number of outcomes (x-axis) for each target in K562 cells (grey lines), and their average (blue 
line). 
 
Figure 4. Local sequence context strongly influences editing outcomes in the explorative 
set of gRNA-target pairs.  
A. Nearby matching sequences are used as substrate for microhomology-mediated repair more 
frequently than distant ones. Fraction of mutated reads (y-axis) for increasing distance between 
1,281 matching sequences of length 9 (x-axis) (blue markers) in K562 cells, and a linear 
regression fit to the trend (solid line; Pearson's R=-0.67). Reproducibility of measurements is 
presented in Figure 5C.  
B. Frequency of microhomology-mediated repair depends on the length of and distance 
between the matching sequences. Same as (A), but linear regression fits only for 
microhomologies of lengths 3 (red, bottom) to 15 (pink, top), with the number of pairs of 
matching sequences considered (N) and Pearson’s correlation (R) noted in the legend.  
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C. Mutations in microhomology sequence reduce repair outcome frequency, but corresponding 
deletions are still present. The fraction of mutated reads associated with the particular 
microhomology with mismatches (y-axis) vs without mismatches (x-axis) stratified by the 
number of mismatches (blue: one mismatch, yellow: two mismatches). Solid lines: linear 
regression fits; dashed black line: y=x; Pearson's R provided in legend.  
D. Single nucleotide insertions are only dominant when repeating the PAM-distal nucleotide. 
Percentage of the 6,572 gRNAs for which insertion of a specific nucleotide is most frequent in 
all replicates (“dominant allele”;  area of wedge) stratified by whether the PAM-distal nucleotide 
adjacent to the cut site is inserted (blue), vs. all other outcomes (green).  
E. Insertions of thymine dominate often, while guanines are rarely inserted with reproducibly 
high frequency. The percentage of gRNAs that have a dominant single nucleotide insertion (y-
axis), stratified by their PAM-distal nucleotide at the cut site (x-axis).  
F. Dominant single nucleotide deletions usually remove one nucleotide from a repeating pair at 
the cut site. Percentage of the 1,511 gRNAs with a dominant single nucleotide deletion (area of 
wedge) of a repeating A (blue), repeating T (teal), repeating G (red), repeating C (orange), or a 
base from a non-repeat (green).  
G. Dominance of single nucleotide deletions depends on both bases adjacent to the cut site. 
The percentage of gRNAs that have a dominant single nucleotide deletion (y-axis), stratified by 
the two bases on either side of the cut site (x-axis).  
H. Two nucleotide deletions that are dominant favour repeats. Percentage of the 1,145 gRNAs 
with a dominant size two deletion (area of wedge) that delete a repeat (XY | XY » XY, teal), 
delete PAM-distal nucleotides (XY | Z » Z, red), delete one PAM-distal and one PAM-proximal 
nucleotide (XY | ZW » XW, purple), delete PAM-proximal nucleotides (Y | ZW » Y, orange), 
delete a PAM-distal nucleotide flanked by a repeating base (XY | X » X, grey), or delete a PAM-
proximal nucleotide flanked by a repeating base (Y | XY » Y, blue). X, Y, Z, W - any nucleotide; | 
- cut site.  
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I. PAM-distal guanine at the cut site promotes, while PAM-distal thymine at the cut site demotes 
the frequency of dominant dinucleotide repeat contraction. The percentage of gRNAs with a 
dinucleotide repeat that have the corresponding dominant two nucleotide deletion (y-axis), 
stratified by the two bases in the repeated sequence (x-axis). 
 
Figure 5. Differences between editing outcomes in K562-Cas9 and other cell lines and 
effector proteins.  
A. Genetic background influences editing outcomes. Average per-gRNA frequency of different 
types of editing outcomes in 3,777 gRNAs (y-axis; colors as 3B) for Chinese hamster ovary cell 
line (CHO), mouse embryonic stem cells (Mouse ESC), human induced pluripotent stem cells 
(iPSCs), human retinal pigmented epithelial cells (RPE-1), human near-haploid cell line (HAP1), 
K562 cell line, and K562 cells with alternative Cas9 proteins: enhanced Cas9 (eCas9), and 
Cas9-TREX2 fusion (TREX2). Separate vertical bars are measurements from biological 
replicates; median number of mutated reads per gRNA is given above the bar for each replicate. 
B. Mutational outcomes are similar across cell lines, with consistent moderate differences in 
stem cells and the K562 Cas9-TREX2 fusion line. Median symmetric Kullback Leibler 
divergence between repair profiles (black to white color range, as in Figure 2B) in different 
tested lines (x and y axis). gRNAs as in A. 
C. Microhomology-mediated repair fidelity is similar across genetic backgrounds, but differs for 
Cas9-TREX2 fusion. Regression lines (as in Fig 4A) for fraction of mutated reads (y-axis) for 
increasing distance between matching sequences of length 9 (x-axis) in K562 cells (blue) and 
other tested lines (colors) in multiple replicates (individual lines), with overall Pearson’s 
correlation denoted in the legend. gRNAs as in Figure 4B, restricted to those 822 gRNAs with 
MH of length 9 and at least 20 mutated reads in all samples. 
D. The type of the dominant outcome per gRNA is consistent across cell lines overall, but 
biased towards microhomology-mediated deletions in stem cells, and I1 insertions in RPE-1 and 
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CHO. The number of gRNAs (color) for which the most frequent indel comes from each class (x-
axis) in the other cell lines examined (panels) compared to that for the same gRNA in K562 (y-
axis). “None” refers to gRNAs without any indel consistently most frequent in all replicates. 
gRNAs as in A. RPE data is based on one replicate, K562 on three, all other cell lines on two 
replicates. 
E. Cas9-TREX2 fusion protein favours larger deletions compared to K562. Deletions of 
increasing size (x-axis) become more frequent (y-axis) in K562 Cas9-TREX2 cells (blue) 
compared to standard K562 Cas9 (orange). gRNAs as in A. 
 
Figure 6. Accurate prediction of repair profiles 
A. Example of a repair profile prediction with accuracy close to the test set median (KL=0.69). 
DNA sequence of the target (top) is edited to produce a range of outcomes in two synthetic 
replicates (dark green, blue bars) and the corresponding predicted outcomes (green bars). The 
proportions (x-axis) of the three largest mutational outcomes (“D5” - deletion of size 5 with 
highlighted size 5 microhomology,  “I1” - insertion of a guanine at the cut site, “D1” - deletion of 
PAM-distal cytosine at the cut site; y-axis) is consistent between the biological replicates and 
the prediction. Stretches of microhomology (green) and inserted sequences (red) are 
highlighted at the cut site (dashed vertical line). 
B. Repair profiles can be predicted from sequence alone. Symmetrised Kullback-Leibler 
divergence (KL, y-axis) between predicted and actual repair profiles (green), as well as between 
biological replicates A and B (blue; x-axis), with median values denoted above. Box plots: 
median line with median value marked, quartile box, 95% whiskers. 6,218 gRNAs as in Figure 
2C; these were not used in training or hyperparameter selection. 
C. Frameshift mutations can be predicted with high accuracy. Measured (x-axis) and predicted 
(y-axis) percent of mutations that do not produce frameshift mutations for 6,218 held-out gRNAs 
as in B (blue), and 12 gRNAs that were deep sequenced in (Shi et al. 2015) (orange). 
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Dot1_e11.3 has over 90% deletions of size greater than 30 in the Shi et al sequencing data so 
we do not expect accurate predictions for this gRNA. 
 
Online Methods  
The code for all analyses is available at https://github.com/felicityallen/SelfTarget , as a 
runnable capsule on www.codeocean.com, and as Manuscript Related File 1. 
Selection of guides and targets 
We compiled our library of 41,630 total gRNA-target pairs (Dataset 1) from five sub-libraries 
aimed at testing different aspects of repair outcome generation: 
 
1. Endogenous gRNA-Targets: We included 86 gRNAs used in7 (“Endogenous targets”) that 
were compatible with our library cloning method (see below), of which 9 were lost during 
cloning, giving 77 in total. 
 
2. Genomic gRNA-Targets: We selected 6,568 gRNAs from existing gRNA libraries or 
literature, which we expect to have sequence characteristics representative of gRNAs in 
practical use. These included the Endogenous set above, as well as 5,431 from the Human v1.0 
library34. Of these, 5,194 were selected because they were also present in the library used in13,35 
- these guides were obtained by filtering for common guides between the two libraries, and then 
discarding those that were incompatible with our assay (see below). The result was a set 
targeting 5,192 different human genes. Further 903 guide-target pairs were included from within 
the set used in13 (again filtered for assay compatibility), which target genes that were considered 
by the authors to be of high value, as they targeted ion channels, receptors and genes in the 
cancer gene census. The remaining 234 gRNAs were designed with other in-house experiments 
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in mind and targeted a range of essential and non-essential genes, or were in the Endogenous 
set above.  
 
3. Explorative gRNA-Targets: We designed 27,906 guides to cover a wide range of local 
sequence characteristics. This included gRNAs with varying stretches, distances, and 
nucleotide compositions of microhomologous sequences as described below. The target 
sequences were randomly generated (except for the PAM) and then adjusted iteratively until the 
desired microhomology properties were achieved, ranging from targets with no 
microhomologous sequences longer than 2 nucleotides within 20 nucleotides of the cut site, to 
targets with microhomologous sequences up to 15 nucleotides long at close range. A larger set 
of gRNA-targets was initially created and then filtered both for compatibility with cloning (see 
below), as well as to ensure each gRNA had no direct targets in the human genome (>1 
mismatch between gRNA and target). The sequences of the resulting set are in Dataset 1, and 
an overview is given in Table S5. 
 
4. Microhomology Mismatch gRNA-Targets: 571 gRNA-targets were randomly selected from 
the Explorative gRNA-Targets above that had microhomology span lengths of 6 and above. 
These were randomly altered to change one (284 gRNAs) or two bases (287 gRNAs) in the 
microhomologous sequence. 
 
5. Conventional Scaffold gRNA-Targets: All of the above subsets used the improved gRNA 
scaffold17. 6,218 gRNA-target pairs, all of which were already included in one of the first three 
subsets above (77 Endogenous, 3,777 Genomic (distinct set from 3,777 used for across cell line 
comparisons), 2364 Explorative), were ordered as separate oligos in the purchased oligo pool 
and were independently cloned with the alternative conventional gRNA scaffold16. These gRNAs 
allowed assessment of the impact of a difference in gRNA scaffold (which appears very small, 
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Figure 2C) as well as providing independently synthesized and constructed repeat 
measurements of the same gRNAs. 
  
Every target is uniquely barcoded by 10nt sequence both in the 3’ and the 5’ end (at least two 
mismatches between any two barcodes, randomly generated), to allow identification of each 
construct even in the absence of the full targeted sequence. All constructs passed the filters of 
having no stretches of five adjacent nucleotides with at least four thymines in the gRNA 
sequence, since this can cause early termination of transcription; carrying no BbsI restriction 
sites or common primer sequences in the gRNA sequence or context, and not cutting elsewhere 
in the plasmid. All constructs were altered to contain a ‘G’ in the gRNA (but not the target) in the 
position 20nt before the PAM, for improved expression of the gRNA from the hU6 promoter. 
Construction of lentiviral library  
A lentiviral gRNA expression vector lacking the scaffold pKLV2-U6(BbsI)-PKGpuro2ABFP-
W was generated by removing the improved gRNA scaffold from pKLV2-U6gRNA5(BbsI)-
PKGpuro2ABFP-W34 (Addgene #67974). This strategy allowed us to clone gRNA-target libraries 
encoding gRNAs linked to either the conventional or the improved scaffold sequences, but 
otherwise identical.  
We generated by PCR on pKLV2-U6gRNA5(BbsI)-PKGpuro2ABFP-W two fragments 
encompassing the 5’ end of the AmpR cassette to U6 promoter (primers P1-P2, Table S6) and 
PGK promoter to the 3’ end of the AmpR cassette (primers P3-P4), respectively. Primer 
overhangs were designed to generate overlapping ends and pKLV2-U6(BbsI)-PKGpuro2ABFP-
W was obtained by Gibson assembly (NEBuilder HiFi DNA Assembly Master Mix, NEB) of the 
two fragments. BbsI restriction sites were present downstream from the U6 promoter for 
subsequent cloning of the gRNA-target library inserts. 
30 
Library cloning started by PCR amplification of the 170 nt oligonucleotide pool of designed 
sequences (CustomArray) encoding gRNA and target sequence, separated by a spacer 
harbouring two BbsI restriction sites (Supplementary Figure 1), enclosed by priming sites, and 
using all the remaining 79nt to randomize the sequence context of the target. Primer pairs P5-
P6 and P7-P8 (Table S6) were used to amplify oligos compatible with the conventional or 
improved scaffold respectively. Gibson assembly36 was employed to fuse the amplified pool to a 
193 nt G-block fragment (IDT) encoding either a conventional or improved version of the gRNA 
scaffold and a spacer. 1:1 molar ratio was mixed in three reactions incubated 1 h at 50ºC and 
subsequently pooled. The resulting 318 bp circular DNA was column purified (PCR purification 
kit, QIAGEN) and treated with Plasmid-Safe ATP-Dependent DNase (Epicentre) to remove 
linear DNA, followed by linearisation with BbsI at 37ºC for 2 h. The resulting 296 bp linear 
fragment was ligated into scaffold-less pKLV2-U6(BbsI)-PKGpuro2ABFP-W. Ligations (T4 DNA 
Ligase, NEB) were performed in triplicate, pooled and used in up to 10 electroporation reactions 
to maximise library complexity.  
Generating the TREX2 construct 
The Cas9-TREX2 and Cas9-2A-TREX2 vectors were made by fusing the human TREX2 
open reading frame (GBlock, IDT) to the C-terminus of the Cas9 protein37 with a GGGS linker or 
an intervening T2A peptide. These were cloned by Gibson assembly into a piggyBac vector 
(pKLV-Cas9), driven by a EFS promoter, and containing a blasticidin selectable marker. 
Genbank files of the final vectors are provided in the Supplementary Information.  
Cell culture 
K562, K562-Cas9 (kind gift by Etienne De Braekeleer) and all K562-derived lines (see 
below) were cultured in RPMI supplemented with 10% FCS, 2 mM L-glutamine, 100 U/ml 
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penicillin and 100 mg/ml streptomycin. CHO-Cas9 and 293FT (Invitrogen) cells were cultured in 
Advanced DMEM supplemented with 10% FCS, 2 mM L-glutamine, 100 U/ml penicillin and 100 
mg/ml streptomycin. HAP1-Cas9 were cultured in IMDM supplemented with 10% FCS, 2 mM L-
glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin. RPE-1-Cas9 cells were cultured in 
DMEM:F12 supplemented with 10% FCS, 0.26% sodium bicarbonate, 2 mM L-glutamine, 100 
U/ml penicillin and 100 mg/ml streptomycin.  
E14TG2a mouse ES cells supplied by Dr Meng Li (Cambridge Stem Cell Institute) were 
cultured in High glucose DMEM supplemented with 15% FBS,  2 mM L-glutamine,  0.1 mM 2-
mercaptoethanol and 1,000 U/ml leukemia inhibitory factor (LIF; Millipore).  
iPSCs (REC 15/WM/0276) were cultured in vitronectin (Life Technologies Ltd.) coated 
plates and TeSR-E8 medium (Stemcell Technologies). E8 media was changed daily throughout 
expansion and all experiments. All cell lines were cultured at 37ºC, 5% CO2. 
Lentivirus production and transduction of cell lines 
Supernatants containing lentiviral particles were produced by transient transfection of 
293FT cells using Lipofectamine LTX (Invitrogen). 5.4 µg of a lentiviral vector, 5.4 µg of psPax2 
(Addgene #12260), 1.2 µg of pMD2.G (Addgene #12259) and 12 µl of PLUS reagent were 
added to 3 ml of OPTI-MEM and incubated for 5 min at room temperature. 36 µl of the LTX 
reagent was then added to this mixture and further incubated for 30 min at room temperature. 
The transfection complex was added to 80% confluent 293FT cells in a 10-cm dish containing 
10 ml of culture medium. After 48 h viral supernatant was harvested and stored at –80 °C. Fresh 
medium was added and lentiviral supernatant was collected a second time 24 h later. When 
necessary we prepared larger amounts of lentivirus by scaling up the procedure above.  
For lentiviral transduction K562 and K562-derived cells (see below), CHO-Cas9, HAP1-
Cas9 and RPE-1-Cas9 cell lines were incubated with the lentiviral supernatant in a single cell 
suspension in presence of 8 µg/ml polybrene (Hexadimethrine bromide, Sigma) followed by 
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centrifugation for 30 min at 1,000xg. E14TG2a mouse ESCs transduction was performed 
incubating cells in suspension for 30 min in presence of 8µg/ml polybrene. iPSC transduction 
was performed in a single cell suspension obtained by incubating cells with Accutase for 10 min 
(Millipore Corporation) and cells were plated in E8 medium supplemented with 8µg/ml 
polybrene.  
Generation of K562-eCas9, K562-Cas9-TREX2, K562-Cas9-2A-TREX2 and 
E14TG2a-Cas9 lines 
Cell lines stably expressing Cas9 were generated by lentiviral transduction followed by 
selection in the presence of Blasticidin (Cambridge Bioscience) to ensure high Cas9 activity. 
K562 cells were transduced using eSpCas9(1.1)21 (Addgene #71814), Cas9-TREX2 and Cas9-
2A-TREX2 vectors to generate K562-eCas9, K562-Cas9-TREX2 and K562-Cas9-2A-TREX2 
respectively. E14TG2a-Cas9 cells were generated by transducing E14TG2a cells with pKLV2-
EF1aBsd2ACas9-W34(Addgene #67978). 
Screening and sequencing of repair outcomes 
Cell lines were infected at a multiplicity of infection (MOI) ranging from 0.5 to 0.6 and at a 
coverage ranging from 500X to 1600X. Total number of cells, MOI and coverage for each 
screen are listed in Table S1. For each line, at least two separate infections were performed and 
treated separately as biological replicates. 24 h after transduction (72 h for iPSCs) puromycin 
was applied to the culture medium to select for successfully transduced cells and maintained 
throughout the screen. Cells were cultured for 7 days post infection, with a small number of 
samples further maintained for up to 20 days to evaluate the effect of timepoint choice (Table 
S1). Enough cells were passaged and collected to maintain coverage higher than at the time of 
infection.  
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Upon collection cells were centrifuged and pellets were stored at -20ºC prior extraction of 
genomic DNA. Briefly, cell pellets were resuspended into 100 mM Tris-HCl pH 8.0, 5 mM EDTA, 
200 mM Nacl, 0.2% SDS and 1 mg/ml Proteinase K and incubated at 55ºC for 16 h. DNA was 
extracted by adding 1 volume of isopropanol followed by spooling, washed twice in 70% 
ethanol, centrifuged and resuspended into TE. 
For sequencing, the region containing the target surrounded by the context was amplified 
by PCR using primers P10-P12 or P11-P12 respectively for the conventional and improved 
scaffold (Table S6) with Q5 Hot Start High-Fidelity 2× Master Mix (NEB) with the following 
conditions: 98 °C for 30 s, 24 cycles of 98 °C for 10 s, 61 °C for 15 s and 72 °C for 20 s, and the 
final extension, 72 °C for 2 min. Alternatively, both gRNA and target were amplified using 
primers P9-P12. For each gDNA sample the amount of input template was calculated keeping 
into account coverage and the amount of gDNA per single cell depending on the species and 
the ploidy of each line, and PCR reactions were scaled up accordingly. The PCR products were 
pooled in each group and purified using QIAquick PCR Purification Kit (QIAGEN). Sequencing 
adaptors were added by PCR enrichment of 1 ng of the purified PCR products using forward 
primer P13 and indexing reverse primer P14 with KAPA HiFi HotStart ReadyMix with the 
following conditions: 98 °C for 30 s, 12-16 cycles of 98 °C for 10 s, 66 °C for 15 s and 72 °C for 
20 s, and the final extension, 72 °C for 5 min. The PCR products were purified with Agencourt 
AMPure XP beads, quantified and sequenced on Illumina HiSeq2500 or HiSeq4000 by 75-bp 
paired-end sequencing using the following custom primers: P15-P18 for sequencing of both 
gRNA and target, P16-P18 (conventional scaffold) or P17-P18 (improved scaffold) for target-
only sequencing. 
Sequence analysis 
We processed the generated sequence data to compile repair profiles as follows. First, 
we combined the partially overlapping paired-end reads into a single sequence using pear 
34 
v.0.9.1038 with options “-n 20 -p 0.1” (minimum combined sequence length of 20, probability of 
no overlap below 0.1). To assign reads to constructs, we required that at least one of the unique 
3’ and 5’ barcodes be present with at most one mutation, and confirm that the read can be 
aligned to the template in such a way that at least 80% of the read characters has a match in 
the construct template (i.e. there can be a large deletion in the read around the cut site, but 
minimal misalignment outside that region). The alignment was done using a custom dynamic 
programming algorithm in which the two sides of the cut site are independently aligned and then 
efficiently combined. This algorithm allows large deletions at a specified place (the expected 
Cas9 cut site) without penalty, while imposing substantial gap penalties elsewhere, and unlike 
generic tools, works for relatively short sequences. Once reads were assigned to oligos we 
checked each sample to ensure that the per-oligo log2 read counts (including those both with 
and without indels) of the “Explorative gRNA-Target” set (since these have no direct targets in 
the genome) were well correlated (Pearon’s R > 0.95, computed using scipy.stats.pearsonr39) 
with those in the original plasmid library to minimize distortion in the measured mutational 
profiles that could be due to reasons other than Cas9-cutting and subsequent cellular repair. 
The mapping and alignment of sequences was first carried out on the plasmid library to 
compile a set of null mutations that are present before any editing experiments. These null 
mutations were then used as templates for alignment of sequencing reads from the screens, 
again using the custom dynamic program, so that mutations already existing in the plasmid 
library (due to oligo synthesis errors or somatic mutation) are not erroneously attributed to Cas9 
activity. Additionally, a deeper measurement was taken of the library in K562 cells without Cas9 
present, processed as for all other samples, and then used to filter the other profiles to remove 
all mutations seen in these non-Cas9 samples unless they were present with at least three 
times their non-Cas9 frequency in the other sample (since, for example, some very low-
frequency technical artifacts can resemble microhomology-mediated deletions). 
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Adequate coverage was ensured by only including gRNAs in the sub libraries described 
above if they had at least 20 mutated reads in all three K562 replicates. For analysis involving 
other cell lines, this criterion was extended to ensure that each gRNA had at least 20 mutated 
reads in all samples employed. For example, the analysis of microhomology effect in non-K562 
cells used a restricted subset of 16,272 gRNA-target pairs from the explorative gRNA target set, 
and the remaining results presented in Figure 5 used 3,777 gRNA-Targets from the Genomic 
gRNA-Targets set, all restricted to those with over 20 mutated reads in all K562 and non-K562 
samples.  
Note that although a proportion of the gRNAs used target essential genes (178 target 
genes in Hart’s essential gene set40), and may therefore be expected to decrease in coverage 
as the assay goes on, the limited duration of the assay (7 days), and the fact that the 
measurement is made at an independent synthetic target rather than at the endogenous gene, 
is expected to result in negligible impact on the mutational profiles measured. Indeed, assuming 
independence of editing events, the only expected effect of fitness differences should be on 
coverage, which we account for by ensuring adequate read counts as above. Correspondingly, 
we observed no bias in KL values for the 189 guides targeting essential genes (as defined by40) 
compared to those that do not (Figure S26). 
Repair profile comparisons 
We store the repair profile as a collection of read counts per indel, where each indel is 
characterised by its size, type and location with respect to the cut site, as specified by an 
identifier string e.g. the identifier ‘D2_L-3R0’ describes a size 2 deletion for which the last 
unaltered nucleotides are 3 to the left of the cut site, and at the cut site, respectively. To 
calculate similarity of repair profiles, we use the symmetrized Kullback-Leibler divergence 
(“KL”). Standard Kullback-Leibler divergence is calculated as 
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𝐷"#(𝑃	||	𝑄) = 	∑, 𝑃, 𝑙𝑜𝑔 0121, 
where i indexes the different indels, and 𝑃, and 𝑄, are their normalized proportion of total 
mutated read counts in the compared samples; we employ the symmetric form, 𝐾𝐿 = 𝐷"#(𝑃||	𝑄) +	𝐷"#(𝑄	||	𝑃). 
To avoid division by zero, we add small pseudocounts of 0.5 to all indels present in one sample, 
but not the other, in the computation. To give the reader a sense of the similarity of profiles with 
various KL values at the respective quantiles and whiskers of our measurements in Figure 6B, 
we provide a series of examples in Figure S19(a-d). 
 
For frame-shift comparisons, we accumulated all reads for all mutations for a given gRNA-target 
such that those mutations whose size are a multiple of 3 are considered “in frame” and those 
whose size are not a multiple of 3 are considered “out of frame”. Unmutated reads were 
discarded from all comparisons (except read counts and mutation rates presented in Figures S2 
and S5). 
Repair profile analysis 
We classified all indels into types I1 (size 1 insertion), D1 (size 1 deletion), D2 (size 2 deletion 
I>1 (larger insertions), I+D (insertion and deletion), and D>2 (larger deletions).  For deletions of 
size greater than 2 we assigned a likely causal mechanism of the event as likely generated by 
microhomology if at least 2nt of matching sequence were present on either side of the cut, and 
likely not generated by microhomology otherwise. To analyse indel prevalence by size (Figure 
3A), we classified indels into deletions of 1-30 nt and insertions of 1 to 10 nt. In this case, 
information about deletions larger than 30 and insertions larger that 10 nt was excluded from the 
analysis since they are not well-detected by our method. In this, and other results presenting 
accumulated measurements across gRNAs (Figure 3A,3B,3C,5A) we first normalized all indel 
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counts for each gRNA by the total number of mutated reads for that gRNA, such that all gRNAs 
weigh equally towards each measurement, rather than proportionally to their read coverage.  
Predicting repair profiles 
For each gRNA-target pair we generated candidate indels by considering all possible insertions 
up to size 2, within 3 nucleotides of the cut site, and all deletions spanning the cut site with a left 
edge from one right of the cut site to up to 30 nucleotides left of the cut site and a right edge up 
to 30 nucleotides the other way, up to a maximum deletion size of 30. For each of these 
candidates, we computed a set of 3,633 binary features that describe the length, location and 
nucleotide composition of inserted sequences, microhomologies and their neighboring 
nucleotides. Many of these features also comprise pairwise ‘AND’ results between features to 
capture interaction effects.  
 
We modelled the probability of each possible outcome using a logistic that ensures the sum of 
all possible outcomes for a give gRNA sums to one. i.e. the probability of the j-th mutation for a 
given gRNA is modelled as 
𝑝8 	= 	𝑒𝑥𝑝(𝜃𝑥8)/=, 𝑒𝑥𝑝(𝜃𝑥,)  
where θ is the vector of parameter weights, and 𝑥8 is the feature vector for that mutation; the 
sum is over all mutations for a particular gRNA.  We then minimize the L2-regularized, non-
symmetric KL divergence of these probabilities when compared to the measured proportions, by 
computing closed form partial gradients with respect to the kth parameter 𝜃> and using L-BFGS-
B within scipy.optimize.minimize to perform gradient descent optimization of this metric39,41. 
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For development of the predictor, we randomly selected gRNA-target pairs from the “Explorative  
gRNA Targets” set, restricted to those with more than 100 reads in K562 cells, and without a 
corresponding counterpart in the “Conventional scaffold gRNA Targets” set, and performed 
training and hyperparameter tuning by randomly selecting two disjoint sets of 
N=50,100,200,500,1000,5000 gRNAs from this set and assigning these to training and test sets 
respectively, and repeating this 3 times for each hyperparameter and training set size. With 
5000 training and test examples, the training and test scores converged for this feature set with 
an L2 regularization constant of 0.01, so the parameters trained with these settings were 
selected for further validation (Figure S27). We used the “Conventional scaffold gRNA Targets” 
set as a held-out validation set, predicting profiles by applying the associated predicted 
probabilities to generate 1000 counts each for all gRNA-target pairs (dropping mutations 
predicted to have less than 1 count). We then validated the accuracy of these profiles by 
comparing against measurements for these gRNA-targets. Replicate A in Figure 6 (and Figure 
2D) summed counts from both 800x DPI7 replicates from the K562 Improved scaffold samples, 
whereas Replicate B used the single replicate 1600x DPI7 sample. 
Endogenous data processing 
We collected the raw read data from the SRA archives referenced by7 and26 and re-processed 
the generated mutations for each gRNA using the same custom alignment program we used for 
our own data. For the Overbeek data, we used the data they collected in K562 at day 11 
following lentiviral transduction, for closest compatibility with our own data, and accumulated 
reads across replicates into a single replicate for each gRNA.  The data for the heights and 
locations of the Shi et al. data used in Figure S23 was obtained via personal communication 
with the authors; we thank them for their assistance. 
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To analyse the influence of chromatin on the results in Figure 2E, we downloaded the 
ChromHMM42 chromatin state assignments for K562 cell line as measured in ENCODE43 from  
http://hgdownload.cse.ucsc.edu/goldenpath/hg19/encodeDCC/wgEncodeAwgSegmentation/wg
EncodeAwgSegmentationChromhmmK562.bed.gz , and used bedtools44 to overlap them with 
the target locations in van Overbeek et al. 
Frame-shift assessment in screen data 
We tested for association between the predicted fraction of out-of-frame outcomes, and the 
gRNA efficacy of known essential genes in three large scale screening datasets; Meyers et al. 
2017 (Avana library)45, Tzelepis et al. 2016 (Yusa v1.0 library)34, and Aguirre et al. 2016 
(GeCKO v2 library)46. Our metric for relative gRNA efficacy was the gRNA scores inferred by 
JACKS47, which provides a multiplier to the expected log-fold response of each gRNA compared 
to other gRNAs targeting the same gene. We used the JACKS inferred gRNA outputs available 
at https://figshare.com/articles/Results/6002438, and restricted the examined associations to 
gRNAs in these sets that target essential genes defined by Hart40. Pearson’s R coefficients 
were calculated using scipy.stats.pearsonr39. 
 
To assess the importance of frame-shift rate for efficacy of gRNA targeting within or outside 
protein domains we mapped genomic location of the cut site to position in a protein for each 
gRNA targeting essential genes. We then found which cut sites are contained within protein 
domains. To do that, we used R package ensembldb and annotation package 
EnsDb.Hsapiens.v75 based on ENSEMBL version 75 and GRCh37 genome assembly48. 
Data availability 
Raw sequence data is available at European Nucleotide Archive (Project accession 
PRJEB12405 / ERP013879; sample accessions provided in Dataset 2). Full code is available at 
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https://github.com/felicityallen/SelfTarget , as a runnable Code Ocean module 
(https://doi.org/10.24433/CO.6bc7bcae-d736-475b-bae5-00ca0562d401) and as Manuscript 
Related File 1. Processed mutational profiles are provided on 
https://figshare.com/articles/processed_mutational_profiles/7312067 
(https://doi.org/10.6084/m9.figshare.7312067) 
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 Supporting Information 
Figure S1. Construct design and cloning approach 
 
 
          
Library cloning started by PCR amplification of the 170 nt oligonucleotide pool of designed 
sequences encoding gRNA and target sequence, separated by a spacer harbouring two 
BbsI restriction sites. Gibson assembly was employed to fuse the amplified pool to a 193 nt 
G- block fragment encoding either a conventional or improved version of the gRNA scaffold 
and a spacer. The resulting 318 bp circular DNA was linearised with BbsI and the 296 bp 
linear product was ligated into scaffold-less pKLV2-U6(BbsI)-PKGpuro2ABFP-W, to produce 
the complete library constructs encoding a functional gRNA expression cassette and its 
target sequence.  
 Figure S2. Fraction of edited targets during outgrowth 
 
 
A. Editing rates are saturated after seven days 
of outgrowth. Number of gRNA-target pairs (y-
axis) with a fraction of mutated reads (x-axis) 
across three, seven, 10, and 20 days of 
outgrowth (columns) for two replicates of K562 
cell lines, and different effector proteins (rows). 
Dashed line: median fraction of mutated reads. 
Overall low rates of cutting (~50%) can be 
explained by synthesis errors and target switching due to viral recombination (B).  B. 
Frequency (y-axis) of fraction of paired end reads that cover a guide RNA sequence on one 
end, and the correct target sequence on the other without any mismatches (x-axis). Top panel: 
sequencing results from the plasmid library. Bottom panel: sequencing results from genomic 
DNA extracts. Dashed line: median fraction of pristine reads. To obtain these data, we re-
sequenced both the plasmid libary and a set of the other samples using a different pair of 
priming sites to capture both gRNA and its target barcode.  
 
 Figure S3. Mutational profiles are consistent across early time points. 
 
Median symmetric Kullback Leibler divergence between repair profiles (black to white color 
range, as in Figure 2B) at different time points (DPI=Days Post Infection) for K562 replicates 
(“A”, “B”, “C”, “D”) of 27,905 gRNAs from the “Explorative gRNA-Target” set (x and y axis). 
Mutational profiles are consistent both within and between replicates until DPI10, after which 
they diverge due to clonal evolution in culture. 
 Figure S4. Proportion of mutated reads per indel type does not change 
substantially over time or across replicates 
 
Frequency of different types of editing outcomes (y-axis; colors as 3B) for K562 replicates 
averaged across 27,905 gRNAs from the “Explorative gRNA-Target” set at various days 
post-infection (DPI). Samples as in Figure S3; colors as in Figure 2B.   
 Figure S5. Coverage across experiments 
 
Number of gRNA-target pairs (y-axis) with a given sequencing coverage (x-axis; log2-scale) 
in the studied cell lines, effector proteins, and replicates. Dashed line: median coverage. 
  
 Figure S6. Comparison of endogenous and synthetic repair profiles for 
Overbeek 25 gRNA 
 
Measured repair profile reproducibility for the outlier, Overbeek 25, gRNA-target pair. DNA 
sequence of the target (top) is edited to produce a range of outcomes in two synthetic 
replicates (green, blue bars) and one endogenous measurement (orange bars). The 
proportions (x-axis) of the four largest mutational outcomes (e.g. “D3” - deletion of three 
base pairs, “I1” - insertion of one base pair, etc.; y-axis) is consistent between the 
experiments. Stretches of microhomology (green) and inserted sequences (red) are 
highlighted at the cut site (dashed vertical line).  
  
 Figure S7. Reproducibility of indel frequencies per gRNA 
 
Number of indels (color) that compose increasing percentage of all mutations observed for 
their gRNA in sample 1 (x-axis) vs sample 2 (y-axis) depending on indel class (rows). 
Columns compare seven days post infection (DPI7) replicate 1 (R1) vs R2 (first column), 
DPI10 R1 vs R2 (second column), DPI7 R1 vs DPI10 R1 (third column), and DPI7 R2 vs 
DPI10 R2 (last column), with Pearson's R reported in the panel. Mutations from 6,568 
gRNAs are represented in the figure. 
  
 Figure S8. Low frequency alleles are unlikely to be sequencing artefacts 
 
Number of distinct indels called for two different K562 replicates, Rep A (800x coverage) and 
Rep C (1600x coverage) and a control experiment carried out in wild type cells (WT, Cas9-, 
800x coverage) for four oligonucleotides with very high sequencing coverage. The indels 
common to K562 and K562 WT (no Cas9) are mutations introduced during oligo synthesis or 
library construction and are removed from consideration in the indel calling code, unless they 
have significantly higher frequency than in the no Cas9 sample. The small number of 
mutations in the WT samples that are not observed in the K562 samples (blue) are indicative 
of the likely number of mutations called due to sequencing artefacts or low frequency oligo-
synthesis mutations. This is a small fraction compared to the number of infrequent indels 
seen in K562 (red, green), which we can conclude are likely caused by Cas9.  
 
 
 
  
 Figure S9. No bias in the side of sequence selected for microhomology-
mediated end joining outcomes 
 
Mutations in microhomology sequence reduce repair outcome frequency, but corresponding 
deletions are still present. For matched pairs of guides, with and without mutations in the 
microhomologous sequence, the fraction of mutated reads associated with the particular 
microhomology (y-axis) is smaller than without mismatches (x-axis) for most gRNAs 
(markers; blue: one mismatch, yellow: two mismatches). The rates of repair are not different 
depending on whether sequence was retained from PAM-distal (left panel) or PAM-proximal 
(right panel) side of the cut. Pearson's R is reported in the legend. 
 
  
 Figure S10. No bias in the side of deletions for non-homologous end 
joining outcomes 
 
Average percent of alternative outcomes for large deletions without microhomology per-
gRNA for 27,905 gRNAs from the “Explorative gRNA-Target” set (Methods). “Blunt” refers to 
deletions that occur exclusively on one side of the cut site and end precisely at the cut site. 
Distal and proximal refer to which side of the cut-site the deletion is on with respect to the 
PAM. “Ambig” refers to those deletions that could not be definitively assigned to an exact 
location (usually due to repeat nucleotides or microhomology of length 1) but could under at 
least one interpretation of their location be considered blunt.   
 Figure S11. GC content of the microhomologous sequence influences 
frequency of microhomology-mediated repair 
 
 
GC content influences microhomology-mediated repair fidelity. Percent gRNA reads with 
length 9 microhomology-mediated deletion (y-axis; boxes median and quartiles, whiskers 5% 
and 95%) across a range of GC contents (x-axis). 750 microhomology-pairs from 674 
gRNAs total.  
 Figure S12. Deletions of size 2 demonstrate strong biases in their 
preferred sequence characteristics, depending on presence of size 1 
and 2 microhomology 
 
 
 
Nucleotides at the cut site bias the frequency of dominant dinucleotide deletion outcomes. 
Percent of dominant outcomes (area of wedge) with given sequence pattern surrounding the 
cut site (colors) for different types of deletions (panels; types as in Figure 4H). X, Y, Z, W, N 
- any nucleotide.   
 Figure S13. Sequence at the cut site biases the rate of deletions of size 
2, depending on repeating single and double nucleotides 
 
Nucleotides at the cut site bias the rate of dominance of dinucleotide deletion. Percent of 
gRNAs for which a dinucleotide deletion is dominant (y axis) with given sequence pattern 
surrounding the cut site (x axis) for different types of deletions (panels; types as in Figure 4H 
and S12). X, Y, Z, W, N - any nucleotide.   
 Figure S14. Example of profile measured across different cell lines 
 
 
 Figure S15. Lack of reproducibility in large insertions in human and 
mouse stem cells 
 
 
Frequency of individual insertions of size at least 2 (x and y axis) in two replicates of human 
iPSCs (left) and mouse ESCs (right) in bins of 2%, colored by number of mutations with the 
corresponding frequency. A very small number of insertions are observed in both replicates. 
Mutations are collected from 6,568 gRNAs.  
 
  
 Figure S16. Repair outcomes from Cas9-TREX2 fusion favour blunt end 
joins with the deletion on the PAM-distal side 
 
Average per-gRNA percent of outcomes for deletions of at least 3nt without microhomology 
for 27,905 gRNAs from the “Explorative gRNA-Target” set (Methods). “Blunt” refers to 
deletions that occur exclusively on one side of the cut site and end precisely at the cut site. 
Distal and proximal refer to which side of the cut-site the deletion is on with respect to the 
PAM. “Ambig” refers to those deletions that could not be definitively assigned to an exact 
location (usually due to repeat nucleotides or microhomology of length 1) but could under at 
least one interpretation of their location be considered blunt.  
 
 
  
 Figure S17. TREX2 overexpression effects on indel class frequencies 
 
 
 
Per-gRNA event frequencies change upon TREX2 expression. Number of individual indels 
(y-axis) as a percentage of all mutations observed for their gRNA (x-axis) separated by 
mutation class (rows), and Cas9/TREX2 construct (columns). 
  
 Figure S18. Cas9-2A-TREX2 has a different influence on repair 
outcomes compared to Cas9-TREX2 
 
The mean frequency (y-axis) of deletion or insertion size (x-axis) across genomic sequence 
targets for three alternative Cas9 effector constructs (colors). 
 
 
  
 Figure S19a. Example predicted mutational profile with KL=0.25 (lower 
whisker on Figure 6b) for predicted vs measured. Two replicate 
measurements in K562 also shown, for which the KL is 0.39. 
 
 
  
 Figure S19b. Example predicted mutational profile with KL=0.57 (lower 
quartile line on Figure 6b) for predicted vs measured. Two replicate 
measurements in K562 also shown, for which the KL is 0.44. 
 
 
 
 
 
 
 
 
 
  
 Figure S19c. Example predicted mutational profile with KL=0.80 (upper 
quartile line on Figure 6b) for predicted vs measured. Two replicate 
measurements in K562 also shown, for which the KL is 0.69. 
 
 
 Figure S19d. Example predicted mutational profile with KL=1.14 (upper 
whisker on Figure 6b) for predicted vs measured. Two replicate 
measurements in K562 also shown, for which the KL is 0.50 
 
 
 
 
 
 
 
  
 Figure S19e. Example predicted mutational profile with competing two 
microhomologies of length 9 (D7 and D16) and KL=0.28 for predicted vs 
measured. Two replicate measurements in K562 also shown, for which 
the KL is 0.56 
 
 
  
 Figure S20. Comparison of allele frequencies from predictions and 
replicates 
  
Density of frequency of mutations estimated by two approaches. Left panel: predicted (y-
axis) vs combined measurement (x-axis); right panel: measurement replicate 1 (x-axis)  vs 
measurement replicate 2 (y-axis), both categorised by mutation type (rows), with Pearson’s 
correlation given. I+D mutations and I>2 mutations are not predicted by the model. Mutations 
are collected from 6,568 gRNAs.  
 Figure S21. The performance of the predictor trained on K562 in other 
cell lines is related to their similarity to K562 
 
 
Box plot of symmetric KL divergence (y-axis; orange line: median; box edges: quartiles; 
whiskers: 5% and 95%) between our predictions, and the measured profiles in different cell 
lines (x-axis) on a subset of 4,722 validation gRNA-target pairs, filtered to contain at least 20 
reads for all gRNAs tested across all samples. Performance is best for K562, and 
unsurprisingly declines more in cell lines for which we observed more dissimilar profiles in 
Figure 5B.  
 Figure S22. Example comparisons between gRNAs measured by Shi et 
al 2015 in the murine MLL-AF9/NrasG12D acute myeloid leukemia cell 
line (RN2), and our predictions (trained on data from K562 cells). 
 
 
 
  
 Figure S23. Predicted rates of in-frame mutation do not explain 
variability in knock-out effect in data from Shi et al. 
 
FORECasT predicted in-frame mutation percentage (colours from blue (low) to red (high)) 
applied to data from Shi et al (Figure 2a,4b-j), which quantifies the phenotypic effect (y-axis) 
for gRNAs targeting different regions of the gene (x-axis; 5’ to 3’) for 10 genes (panels), with 
protein domains highlighted in grey rectangles. There is no obvious relationship between the 
heights of the bars and their colour, either within domain or outside domain, and in the 5’ or 
3’ end of the gene. 
  
 Figure S24. Predicted out-of-frame fraction is positively correlated with 
gRNA efficacy 
 
Density (x-axis) of Pearson’s correlation coefficients (y-axis) calculated between JACKS-
inferred gRNA efficacy (Allen et al. 2018) and predicted out-of-frame mutation rate for 
essential genes from three genome-wide libraries (colors; x-axis panels):  (Meyers et al. 
2017) (Avana library), (Tzelepis et al. 2016) (Yusa v1.0 library), and Aguirre et al 2016 
(Aguirre et al. 2016) (GeCKO v2 library). Median values marked on the plot and denoted 
above the violins (central marker); range given as external line markers. Number of genes 
making up the density is provided below the library labels.  
 Figure S25. Fraction of out-of-frame mutations is more important for 
gRNA efficacy when gRNAs target outside protein domains. 
 
JACKS-inferred gRNA efficacy (y-axis) and predicted out-of-frame mutation rate (x-axis) for 
gRNAs targeting essential genes from three genome-wide libraries (rows) stratified by 
gRNAs targeting outside (left column) and inside (right column) protein domains. Pearson’s 
correlation with corresponding p-value, linear model fit, and dataset size is given on the plot. 
 
 
 
 
  
 Figure S26. Gene essentiality has no impact on mutational profile 
reproducibility 
 
 
As Figure 2C, but restricted to gRNAs targeting targeting essential genes (left panel; 
between replicate median KL=0.73) and non-essential genes (right panel; between replicate 
median KL=0.74) as defined by (Hart et al. 2017). Box plots: orange median line, quartiles 
for box edges, 95% whiskers. 
 
  
 Figure S27. Exploration of model hyperparameters and training set size  
 
Optimizing FORECasT model hyperparameters and training set size in using random 
samples from the Explorative gRNA-target set (disjoint set from hold-out guides used in 
validation). The selected model used all regularization parameters set to 0.01 and trained on 
5000 gRNAs (yellow, right-most markers). At this point the average KL values of the training 
and test set have converged, indicating an absence of over-fitting. The KL values used here 
are asymmetric and so give smaller values than those reported in all other measurements. 
 
  
  
Table S1. Screen conditions 
 
Cell line Cells 
(x106) 
Multiplicity 
of infection 
Coverage (cells 
per construct) 
Replicates Time points sequenced 
(days post infection) 
K562-Cas9 70 0.6 800 2 3-7-10-20 
K562-Cas9 140 0.6 1600 2 3-7, 2-5 
K562-Cas9 with 
conventional scaffold 
16, 16, 32 0.5 800,800,1600 3 7 
K562-eCas9 70 0.6 800 2 3-7-10 
K562-Cas9-TREX2 70 0.6 800 2 3-7-10 
K562-Cas9-2A-TREX2 70 0.6 800 2 3-7-10 
RPE-1-Cas9 52 0.5 500 1 7 
HAP1-Cas9 83 0.5 800 2 7 
CHO-Cas9 83 0.5 800 2 7 
iPSC-Cas9 83 0.5 800 2 7 
E14TG2a-Cas9 83 0.5 800 2 7 
K562-No Cas9 70 0.6 800 1 7 
K562-No Cas9 with 
conventional scaffold 
16 0.5 800 1 7 
 
  
 Table S2. Average KL divergence between synthetic and endogenous 
measurements stratified by ChromHMM classification 
 
ChromHMM  Median KL Number of endogenous target regions 
CtcfO 0.79 3 
DnaseD 0.95 3 
ElonW 1.26 1 
Enh 2.73 1 
EnhF 1.00 2 
EnhW 0.74 1 
EnhWF 0.75 2 
Gen3’ 1.23 5 
Gen5’ 1.12 7 
Low 0.99 9 
PromP 1.79 2 
Quies 0.99 9 
Repr 1.11 5 
ReprW 1.25 7 
Tss, or “Active Promoter” 1.16 20 
“Enhancer” (EnhWF, EnhF, 
Enh, EnhW) 
0.82 6 
“Transcription” (Elon, ElonW, 
Gen3, Gen5, Pol2) 
1.14 13 
“Repressed” (Quies, Repr, 
ReprW) 
1.04 21 
 
  
 Table S3. Strongest feature values for prediction. Note that insertion 
features tend to feature more strongly because there are less of them. 
 
Feature Symbol θ value/s Description 
I1Rpt 0.744 Single nucleotide insertion repeating the PAM distal 
nucleotide adjacent to the cut site 
IL-1--1, IL-2--2 0.996, 0.576 Insertion at the cut site 
PW_CS0_NT=G_vs_I1Rpt 0.473 I1Rpt and G at the PAM-proximal nucleotide adjacent to 
the cut site 
PW_CS-1_NT=T_vs_I1Rpt 0.413 I1Rpt and T at the PAM-distal nucleotide adjacent to the 
cut site 
PW_I1_T_vs_I1Rpt 0.408 Single nucleotide insertion repeating the PAM distal 
nucleotide adjacent to the cut site in which a T is inserted 
PW_CS-2_NT=C_vs_I1Rpt 0.404 Single nucleotide insertion repeating the PAM distal 
nucleotide when there is a C in the next most distal 
nucleotide. 
PW_CS2_NT=A_vs_I1Rpt 0.375 Single nucleotide insertion repeating the PAM distal 
nucleotide when there is an A next to the start of the PAM. 
PW_No MH_vs_DL-1--1 0.341 No microhomology, blunt-end deletion on PAM-proximal 
side 
PW_CS-1_NT=A_vs_I1Rpt 0.300 I1Rpt and A at the PAM-distal nucleotide adjacent to the 
cut site 
PW_D>12_vs_DL>=0 0.294 Deletions greater than 12 and ambiguity of location in the 
left side of the deletion (indicates microhomology). 
PW_I1_A_vs_I1Rpt 0.290 Single nucleotide insertion repeating the PAM distal 
nucleotide adjacent to the cut site in which an A is 
inserted 
PW_R-1_NT=G_vs_DR0-0 0.244 Blunt deletion on the PAM-distal side of the cut site if 
there is a G as the first removed nucleotide closest to the 
cut site. 
...   
>3000 other features   
...   
I1_G -0.327 Single nucleotide insertion of a G 
PW_D>12_vs_DR0-0 -0.388 Blunt-end deletion on PAM-distal side of cut of size 
greater than 12 
 
  
 Table S4. Evaluation of predicted rates of in-frame mutation in 12 deep-
sequenced gRNAs from Shi et al. 
 
gRNA Percent predicted 
in-frame 
mutations 
Percent measured 
in-frame 
mutations 
Predicted vs 
Measured KL 
Percent deletions 
with size > 30 in 
measured profile 
Brd4_e3.1 32.3 34.2 1.0 12.6 
Brd4_e3.3 30.6 18.6 1.3 8.5 
Brd4_e4.1 17.3 13.8 1.5 4.9 
Dot1l_e1.1 31.5 29.4 0.78 10.0 
Dot1I_e3.1 28.3 26.7 0.72 8.9 
Dot1I_e7.1 25.2 23.1 1.2 13.9 
Dot1I_e11.1 26.5 42.8 6.0 91.2 
Ezh2_e2.2 22.7 18.1 1.1 13.9 
Ezh2_e19.2 36.8 24.6 0.83 7.0 
Smarca4_e2.1 34.7 22.4 1.8 3.67 
Smarca4_e3.1 26.1 27.5 1.1 11.6 
Smarca4_e16.1 30.6 37.5 1.0 15.8 
 
  
 Table S5. Characteristics of explorative guide set 
 
 
Length of 
Microhomology 
Number of gRNA-Targets with microhomology at distance. 
< 5 < 10 < 20 
3 7923 15236 26141 
4 2956 6459 15627 
5 1143 2517 5509 
6 591 1355 2732 
7 394 935 1748 
8 321 775 1372 
9 280 674 1212 
10 279 678 1144 
11 313 712 1124 
12 284 650 1026 
13 267 648 1040 
14 285 698 1106 
15 259 649 987 
 
  
 Table S6. Primer sequences (5’ > 3’) 
 
Cloning of pKLV2-U6(BbsI)-PKGpuro2ABFP-W 
P1 GGCAGCACTGCATAATTCTCTTAC 
P2 CCTACCCGGTAGAATTGGATCCAAACGTGTCTTCTCGAAGACCC 
P3 GTAAGAGAATTATGCAGTGCTGCC 
P4 GGGTCTTCGAGAAGACACGTTTGGATCCAATTCTACCGGGTAGG 
Amplification of oligo pools for library cloning 
P5 GGAAACTACACTTGCCTGGC 
P6 AACTTGCTATTTCTAGCTCTAAAAC 
P7 GACGTCCAGAGCACAGATGG 
P8 GCTGTTTCCAGCATAGCTCTTAAAC 
Preparation of sequencing libraries 
P9 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGTGGAAAGGACGAAACA 
P10 ACACTCTTTCCCTACACGACGCTCTTCCGATCTGGAAACTACACTTGCCTGGC 
P11 ACACTCTTTCCCTACACGACGCTCTTCCGATCTGACGTCCAGAGCACAGATGG 
P12 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTACCCGGTAGAATTGGATCCAAAC 
P13 AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT 
P14* CAAGCAGAAGACGGCATACGAGATN10GAGATCGGTCTCGGCATTCCTGCTGAACCGCTCTTCCGATC
T 
Sequencing primers 
P15 TCTTCCGATCTCTTGTGGAAAGGACGAAACACCG 
P16 CTCTTCCGATCTGACGTCCAGAGCACAGATGG 
P17 GCTCTTCCGATCTGGAAACTACACTTGCCTGGC 
P18 CGCTCTTCCGATCTACCCGGTAGAATTGGATCCAAAC 
*: N10, index for multiplexed sequencing. 
 
 
